Journal ArticleDOI
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
David M. Reid,Jean-Pierre Devogelaer,Kenneth G. Saag,Christian Roux,Chak Sing Lau,Jean-Yves Reginster,Philemon Papanastasiou,Alberto Ferreira,F. Hartl,T. Fashola,Peter Mesenbrink,Philip N. Sambrook +11 more
TLDR
Zoledronic acid was non-inferior and superior to risedronate for increase of lumbar spine bone mineral density in both the treatment and prevention subgroups at 12 months.About:
This article is published in The Lancet.The article was published on 2009-04-11. It has received 440 citations till now. The article focuses on the topics: Risedronate Sodium & Zoledronic acid.read more
Citations
More filters
Journal ArticleDOI
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
Alexandra Papaioannou,Suzanne N Morin,Angela M. Cheung,Stephanie A. Atkinson,Jacques P. Brown,Sidney Feldman,David A. Hanley,Anthony B. Hodsman,Sophie A. Jamal,Stephanie M. Kaiser,Brent Kvern,Kerry Siminoski,William D. Leslie +12 more
TL;DR: There has been a paradigm shift in the prevention and treatment of osteoporosis and fractures, and the focus now is on preventing fragility fractures and their negative effects.
Journal ArticleDOI
An overview and management of osteoporosis
TL;DR: Increasing awareness among doctors, which, in turn, facilitates increase awareness of the normal populace, will be effective in preventing this epidemic of osteoporosis.
Journal ArticleDOI
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy
Dora Liu,Alexandra Ahmet,Leanne M Ward,Preetha Krishnamoorthy,Efrem D. Mandelcorn,Richard Leigh,Jacques P. Brown,Albert Cohen,Harold Kim,Harold Kim +9 more
TL;DR: This comprehensive article reviews these adverse events of systemic corticosteroid therapy and provides practical recommendations for their prevention and management based on both current literature and the clinical experience of the authors.
Journal ArticleDOI
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.
Jennifer M. Grossman,Rebecca Gordon,Veena K. Ranganath,Chad L. Deal,Liron Caplan,Weiling Chen,Jeffrey R. Curtis,Daniel E. Furst,Maureen McMahon,Nivedita M. Patkar,Elizabeth R. Volkmann,Kenneth G. Saag +11 more
TL;DR: Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient.
Journal ArticleDOI
UK clinical guideline for the prevention and treatment of osteoporosis
Juliet E. Compston,A Cooper,Cyrus Cooper,Neil Gittoes,Celia L Gregson,Nicholas C. Harvey,S Hope,John A. Kanis,Eugene V. McCloskey,Kenneth E. S. Poole,David M. Reid,Peter Selby,F. Thompson,Anne Thurston,N Vine +14 more
TL;DR: The guideline, which has received accreditation from the National Institute of Health and Care Excellence (NICE), provides a comprehensive overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.
References
More filters
Journal ArticleDOI
Prediction of Creatinine Clearance from Serum Creatinine
Donald W. Cockcroft,M H Gault +1 more
TL;DR: A formula has been developed to predict Creatinine clearance from serum creatinine (Scr) in adult males: Ccr = (140 – age) (wt kg)/72 × Scr (mg/100ml) (15% less i).
Journal Article
EuroQol : a new facility for the measurement of health-related quality of life
Journal ArticleDOI
Vertebral fracture assessment using a semiquantitative technique
TL;DR: The semiquantitative approach can be applied reliably in vertebral fracture assessment when performed using well‐defined criteria, and this approach was compared with a quantitative morpho‐metric approach.
Journal ArticleDOI
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black,Pierre D. Delmas,Richard Eastell,Ian R. Reid,Steven Boonen,Jane A. Cauley,Felicia Cosman,Peter L. Lakatos,Ping Chung Leung,Z. Man,Carlos Mautalen,Peter Mesenbrink,Huilin Hu,John Caminis,Karen Tong,Theresa Rosario-Jansen,Joel S. Krasnow,Trisha F. Hue,Deborah E. Sellmeyer,Erik Fink Eriksen,Steven R. Cummings +20 more
TL;DR: Treatment with zoledronic acid reduced the risk of morphometric vertebral fracture by 70% during a 3-year period, as compared with placebo.
Journal ArticleDOI
Zoledronic acid and clinical fractures and mortality after hip fracture
Kenneth W. Lyles,Cathleen S. Colón-Emeric,Jay Magaziner,Jonathan D. Adachi,Carl F. Pieper,Carlos Mautalen,Lars Hyldstrup,Chris Recknor,Lars Nordsletten,Kathy A. Moore,Catherine Lavecchia,Jie Zhang,Peter Mesenbrink,Patricia K. Hodgson,Ken Abrams,John J. Orloff,Zebulun D. Horowitz,Erik Fink Eriksen,Steven Boonen +18 more
TL;DR: An annual infusion of zoledronic acid within 90 days after repair of a low-trauma hip fracture was associated with a reduction in the rate of new clinical fractures and with improved survival.
Related Papers (5)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black,Pierre D. Delmas,Richard Eastell,Ian R. Reid,Steven Boonen,Jane A. Cauley,Felicia Cosman,Peter L. Lakatos,Ping Chung Leung,Z. Man,Carlos Mautalen,Peter Mesenbrink,Huilin Hu,John Caminis,Karen Tong,Theresa Rosario-Jansen,Joel S. Krasnow,Trisha F. Hue,Deborah E. Sellmeyer,Erik Fink Eriksen,Steven R. Cummings +20 more
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
Zoledronic acid and clinical fractures and mortality after hip fracture
Kenneth W. Lyles,Cathleen S. Colón-Emeric,Jay Magaziner,Jonathan D. Adachi,Carl F. Pieper,Carlos Mautalen,Lars Hyldstrup,Chris Recknor,Lars Nordsletten,Kathy A. Moore,Catherine Lavecchia,Jie Zhang,Peter Mesenbrink,Patricia K. Hodgson,Ken Abrams,John J. Orloff,Zebulun D. Horowitz,Erik Fink Eriksen,Steven Boonen +18 more